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Abstract
Background
This pilot study examined long-term pulse wave velocity (PWV) and peak oxygen uptake
(VO2peak) outcomes following a 12-week moderate-intensity aerobic or resistance training
programme in kidney transplant recipients.
Method
Single-blind, bi-centre randomised controlled parallel trial. 42 out of 60 participants com-
pleted a 9-month follow-up assessment (Aerobic training = 12, Resistance training = 10 and
usual care = 20). Participants completed 12 weeks of twice-weekly supervised aerobic or
resistance training. Following the 12-week exercise intervention, participants were transi-
tioned to self-managed community exercise activity using motivational interviewing tech-
niques. Usual care participants received usual encouragement for physical activity during
routine clinical appointments in the transplant clinic. PWV, VO2peak, blood pressure and
body weight were assessed at 12 weeks and 12 months, and compared to baseline.
Results
ANCOVA analysis, covarying for baseline values, age, and length of time on dialysis pre-
transplantation, revealed a significant mean between-group difference in PWV of -1.30 m/
sec (95%CI -2.44 to -0.17, p = 0.03) between resistance training and usual care groups.
When comparing the aerobic training and usual care groups at 9-month follow-up, there
was a mean difference of -1.05 m/sec (95%CI -2.11 to 0.017, p = 0.05). A significant mean
between-group difference in relative VO2peak values of 2.2 ml/kg/min (95% CI 0.37 to 4.03,
p = 0.02) when comparing aerobic training with usual care was revealed. There was no
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significant between group differences in body weight or blood pressure. There were no sig-
nificant adverse effects associated with the interventions.
Conclusions
Significant between-group differences in 9-month follow-up PWV existed when comparing
resistance exercise intervention with usual care. A long-term between-group difference in
VO2peak was only evident when comparing aerobic intervention with usual care. This pilot
study, with a small sample size, did not aim to elucidate mechanistic mediators related
to the exercise interventions. It is however suggested that a motivational interviewing
approach, combined with appropriate transition to community training programmes, could
maintain the improvements gained from the 12-week exercise interventions and further
research in this area is therefore warranted.
Trial registration
study number: ISRCTN43892586.
Background
Kidney transplantation improves survival, quality of life, and is more cost-effective than other
treatment for end stage renal disease (ESRD) [1, 2]. Despite this, the incidence of cardiovascu-
lar disease (CVD) remains 3 to 5 times higher in kidney transplant (KTx) recipients than the
general population [3]. This is thought to be due to a high prevalence of comorbidities, physio-
logical stressors experienced whilst receiving haemodialysis [1], episodes of rejection, or use of
immunosuppressant medications [3, 4]. Therefore, cardiovascular risk (CVR), and potential
interventions that reduce it, is of upmost importance in this patient population.
Low physical activity levels are associated with metabolic syndrome, CVD, and abnormal
glucose tolerance in KTx recipients [5, 6]. In contrast, higher levels of physical activity in KTx
recipients have been associated with a reduction in incidence of CVD and all-cause mortality
[6, 7]. Several small studies have suggested short-term exercise related benefits in kidney
transplant patients [8–11]. However engagement in long-term behavioural change appears
challenging. A recent systematic review [12] demonstrated medium level evidence of motiva-
tional interviewing techniques to increase physical activity in patients with chronic disease.
Approaches to facilitate engagement and promote lifestyle behavior change may provide long-
term engagement with physical activity, and result in reduction in CVD risk factors.
Pulse wave velocity (PWV), the gold standard measure of arterial stiffness [13], has been
shown to predict mortality in patients with essential hypertension [14], end-stage kidney dis-
ease [15] and more recently it has been shown to be a strong predictor of CVD in KTx recipi-
ents [16]. Studies in haemodialysis (HD) patients have shown that three months of Aerobic
Training (AT) [17, 18] or resistance training (RT) [19] can induce improvements in PWV. A
recently published Randomised Controlled Trial (RCT) from our research team [11], reported
significant improvements in PWV immediately post 12 weeks of either supervised aerobic or
resistance training, when compared with usual care (UC), in KTx recipients. Long-term out-
comes are of utmost importance when evaluating the clinical importance of interventions.
Small exercise studies by Mustata et al [17] and Toussaint et al [18], in HD patients, have
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shown that following one-month cessation of an exercise intervention, PWV values revert
back to pre-intervention baseline levels.
Reduced cardiorespiratory fitness, as measured by peak oxygen uptake (VO2peak) has been
shown to predict survival in haemodialysis patients [20] and KTx recipients [21]. Four RCTs
have shown improvements in VO2peak immediately post exercise intervention in KTx recipi-
ents [8–11]. No studies to date have investigated the long-term effects of RT or AT interven-
tions on PWV or VO2peak in KTx recipients after intervention has ceased. A study by Painter
et al [8] did report gains in VO2peak at 12 months. However, this was with a 12-month aerobic
home exercise programme. The purpose of this pilot study was to investigate the long-term
effects of a 12 week supervised aerobic or resistance training intervention at 9-month follow-
up.
Methods
Ethics statement
Ethical approval, in accordance with the Helsinki Declaration, was sought and obtained from
the London and St Giles Ethics committee, and Research & Development teams at both sites
granted approval for the ExeRT study on the 20th of December 2012 (REC number: 12/LO/
1644, IRAS project ID: 75391). An amendment to include VO2peak assessment at 9-month
follow-up was approved on the 11th of June 2014 date by the London and St Giles Ethics Com-
mittee, and Research and Development teams at both sites. The study was registered and con-
firmed for inclusion on the UKCRN portfolio on the 20/11/2012. The link to the ISRCTN
registration was not received from the UKCRN until the 30/07/2014, and the trial was there-
fore registered on the 31/07/2014. As this was an unintentional process error, an editorial note
is in situ on the trial website (www.isrctn.com; study number: ISRCTN 43892586). The study
was not amended in any way after initial registration with the UKCRN. The authors confirm
that all ongoing and related trials for this intervention are registered.
Participants
This current study reports the 9-month follow-up results of the Exercise in Renal Transplant
(ExeRT) study cohort [11]. This study was a single-blind parallel, randomised controlled trial.
60 participants were recruited and consented to the original ExeRT pilot study [11] from
March 2013 to October 2014. Potential participants were given verbal and written information,
and consented two weeks later if willing to participate.
Participants were included if they were 18 years of age or older, able to provide written con-
sent, and if they had received a kidney transplant in the preceding 12 months. They were
excluded if they were unable to walk 50 metres independently, were pregnant, had participated
in a structured exercise programme in the past six months, or if they had any medical condi-
tion that would preclude participation.
A sample size of 37 in each group will have 80% power to detect a mean difference of 1.8 m/
sec [17] in PWV between either exercise group (AT and RT) or the UC group.
Assuming that the common standard deviation is 2.7, (effect size = 0.7), using a one-way
analysis of variance with a 0.05 two-sided significance level. Adjusting this for an anticipated
attrition rate of 20% gives a final sample size of 132 (44 in each group). The published Minimal
clinically important difference (MCID) for PWV is a reduction of 1 m/s [16]. The ExeRT pilot
study recruited 60 participants.
Participants were randomised after baseline assessment to either 12 weeks of supervised
aerobic training, resistance training or usual care by computer randomization. This was per-
formed by an independent member of the research team. Participants were asked not to
Long-term exercise outcomes in kidney transplant recipients
PLOS ONE | DOI:10.1371/journal.pone.0171063 February 3, 2017 3 / 14
disclose their allocation during assessments, ensuring blinding of research assistants. All time
point assessments baseline, 12 weeks and 9-month follow-up post intervention (12 month
time-point) were conducted between April 2013 and July 2015. All 9-month follow-up assess-
ments were collected within a 14-day window and in a single research visit at a clinical
research facility. The measurements were collected at the same time of day, and in the same
order, as previous baseline and 12-week assessments.
Primary outcome
The primary outcome for this study was PWV. PWV was measured using the Vicorder system
(Skidmore Industries, UK) at 9-month follow-up and compared to measures recorded at base-
line and 12 weeks. Arterial stiffness was assessed at the systemic region (carotid-femoral
PWV), the gold standard method [13]. Conditions for assessment, as stated by the expert con-
sensus statement by Laurent et al [22], were adhered to for all measurements. The measure-
ment protocol by Hickson et al [23] was used mathematically removing the additional femoral
segment from the Vicorder standard protocol, to correct for any inherent bias at high arterial
PWV, and also accounting for participants mean blood pressure value. The average of 3 mea-
surements (of 20 consecutive signals) was recorded at each time point.
Secondary outcomes
Cardiorespiratory fitness. VO2peak was determined during an incremental recumbent
cycling exercise tolerance protocol. Breath-by-breath gas exchange was measured using a Cor-
tex metalyser system, (MetaLyzer1 3B cardiopulmonary exercise testing equipment, Cortex,
Germany) calibrated prior to each patient assessment. The exercise protocol started with 3
minutes of cycling without resistance, and this increased by 15 watts/minute until one of the
following occurred: i) a plateau in oxygen uptake ii) attainment of a respiratory exchange ratio
of 1.15 or greater, or iii) patient request to stop. The average oxygen uptake of the final 20 sec-
onds of the test was recorded as the VO2peak. ECG monitoring, blood pressure, and heart rate
were continuously recorded throughout the incremental test to ensure participants safety.
Anthropometric measures and resting blood pressure. Body weight assessment was
recorded, and height was measured using a calibrated stadiometer. After sitting quietly for 5
mins, resting blood pressure was recorded in triplicate, with a 1-min interval between mea-
surements, using an automated sphygmomanometer (Tango; SunTech Medical, Oxfordshire,
UK). The average of the 3 readings was recorded.
Exercise intervention
Participants randomized to either intervention group (AT or RT) were offered twice-weekly
supervised, and once-weekly home-based, individually tailored exercise training for 12 weeks
at King’s College Hospital (KCH) or Guys and St Thomas’ Hospital (GSTT). Both interven-
tions (AT and RT) were provided at hospital outpatient gyms by a senior renal physiotherapist
and a physiotherapy assistant. Once a week, 30-minute, physiotherapist led patient education
was also provided. Topics included; the role of exercise in renal disease, personalizing exercise
plans, goal settling, long-term community exercise options, problem solving and overcoming
barriers and a question and answer session. Motivational interviewing techniques [24] were
utilized throughout the supervised exercise interventions, and to encourage engagement with
the self-management exercise activity plans. At completion of 12-week interventions, all AT or
RT participants were encouraged to engage with self-managed community exercise pathways
and remain physically active. After this facilitation to community exercise at 12 weeks, patients
received no further intervention. Participants in the usual care group were not provided with
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any specific exercise guidance, they received general exercise encouragement from nursing
staff or nephrologists at routine clinic appointments. For further information on the super-
vised intervention see Greenwood et al [11].
Statistical analysis
This current study reports the long-term follow-up data of the 42 remaining ExeRT study par-
ticipants who were assessed at 9-month follow-up. The results were compared with baseline
and 12-week data from the ExeRT study [11]. Descriptive data were recorded including base-
line characteristics for dropouts. Statistical analysis of outcomes was completed using an as-
treat analysis [25] and SPSS version 22 (PASW Chicago 11). A significance level of p<0.05 was
accepted. Before statistical testing, data was checked for normality. ANCOVA analyses covary-
ing for time on dialysis pre-transplant, age and baseline values were employed to detect mean
between-group differences at 9-month follow-up. Paired t-tests with Bonferroni correction
(set at 99% error) were utilised to assess within-group differences in data from 12 weeks to
9-month follow-up assessment.
Results
42 participants remained in the study at 9-month follow-up assessment (Fig 1), with a 30%
attrition rate. There were 27 males and average age was 51.8±12.5 years, with a mean trans-
plant vintage of 28.6±19.6 weeks. Time on dialysis prior to transplant was 30 [5.75–54.25]
months. PWV was assessed at 9-month follow-up in all 42 patients. VO2peak was assessed in
37 of the 42 subjects at 9-month follow-up assessment. 5 subjects were unable to complete
VO2peak testing at 9-month follow-up due to musculoskeletal knee pain (AT = 1, RT = 2), and
2 participants (AT) were awaiting cardiac investigations for conditions unrelated to the inter-
vention. The modified consort diagram in Fig 1 shows the participant flow in the study. Partic-
ipant characteristics including dropouts from 12 weeks to 9-month follow-up (n = 46) are
reported in Table 1.
There were 14 hospitalisations (30%) across the sample, 1 planned and 7 unplanned admis-
sions in the UC group, 1 planned and 3 unplanned in the AT group and 1 planned and 1
unplanned admission in the RT group. There were two cardiovascular events (one in the AT
and one in the RT group). One of these participants (RT group) was considered to be non-
compliant with all medications, and had a myocardial infarction that was deemed to be unre-
lated to the exercise intervention. The other participant (AT group) was non-compliant with
the exercise intervention and was investigated for a pre-existing cardiac issue. There were
six episodes of rejection, six participants developed new onset of diabetes after transplant
(NODAT), and there were no deaths across the sample, see Table 1.
Primary outcome (PWV)
Table 2 below depicts data at baseline, 12 weeks, 9-month follow-up assessment and ANCOVA
analysis. Data at baseline and 12 weeks are reproduced with permission, from Greenwood et al
[11]. There were no significant within-group changes in PWV from the 12-week to 9-month
follow-up assessment. However, ANCOVA analysis revealed a significant mean between-
group difference in PWV of -1.30 m/sec (95%CI -2.44 to -0.17, p = 0.03) between the RT and
UC groups. When comparing AT and UC groups at 9-month follow-up, the mean difference
was approaching significance, -1.05m/sec (95%CI -2.11 to 0.017, p = 0.05). Fig 2 depicts indi-
vidual PWV results across the three time points in all participants remaining in the study at
9-month follow-up assessment (n = 42).
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Secondary outcomes
There were no significant within-group differences in the AT, RT or UC groups from the
12-week to the 9-month follow-up assessment in absolute or relative VO2peak values, Respiratory
exchange ratio (RER), resting blood pressure or weight (Table 2). On ANCOVA analysis, there
was however a significant mean between-group difference in relative VO2peak of 2.2 ml/kg/min
Fig 1. CONSORT flow diagram. Demonstrating flow of participants throughout the study at baseline, 12
weeks, 12 months (9-month follow-up), and those included in final analysis.
doi:10.1371/journal.pone.0171063.g001
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(95% CI 0.37 to 4.03, p = 0.02) between the AT and UC groups. The mean between-group differ-
ence in relative VO2peak of 0.89 ml/kg/min (95%CI -1 to 2.9, p = 0.4) between the RT and UC
groups was not statistically significant. (See Table 2 and Fig 3). There were no significant
between-group differences in resting blood pressure or weight scores between AT or RT and UC
at 9-month follow-up assessment.
Discussion
This is the first study to examine the potential long-term outcomes in PWV and VO2peak out-
comes following a supervised 12-week AT or RT intervention in new KTx recipients. 9-month
follow-up PWV results suggest a significant between-group difference of -1.30 m/sec when
comparing the resistance training group with usual care. A minimal clinically important differ-
ence (MCID) of a reduction of 1m/sec in PWV has been strongly associated with decreased
cardiovascular disease risk in KTx recipients [16]. It is of note that the between-group differ-
ence in PWV of -1.05m/sec, when comparing the AT and UC group, was a MCID result
although this did not achieve statistical significance (p = 0.05).
Table 1. Participant baseline demographics and 9-month follow-up outcomes.
Variable Total sample (n = 46) UC (n = 20) AT (n = 13) RT (n = 13)
Age (Mean years) 51.8±12.5 49.5±10.6 53.9±10.7 54.6±10.6
Males 27 (58.7) 10 (50) 10 (77) 7 (54)
Ethnicity 1. W = 24 (52)
2. B = 19 (41)
3. A = 3 (6)
1. W = 10 (50)
2. B = 9(45)
3. A = 1(5)
1. W = 7 (54)
2. B = 5(38)
3. A = 1(8)
1. W = 7(58)
2. B = 5(38)
3. A = 1(8)
Transplant vintage (Mean weeks) 28.6±19.6 27.7±17.4 26.5±21.1 32.1±22.3
Transplant characteristics 1. 1st = 35(76.1)
2. 2nd = 5(10.9)
3. 3rd = 2 (4.3)
4. SPK = 4 (8.7)
1. 1st = 16 (80)
2. 2nd = 2 (10)
3. 3rd = 1 (5)
4. SPK = 1 (5)
1. 1st = 11(84.6)
2. 2nd = 2 (5.4)
1. 1st = 8 (61.5)
2. 2nd = 1 (7.7)
3. 3rd = 1 (7.7)
4. SPK = 3(23.1)
Transplant type 1. L = 18 (39.1)
2. C = 28 (60.9)
1. L = 6 (30)
2. C = 14 (70)
1. L = 8 (61.5)
2. C = 5 (38.5)
1. L = 4 (30.8)
2. C = 9 (69.2)
Time on dialysis (Median [IQR]) 30 [5.75–54.25] 41.5 [18.5–52] 34.0 [9.8–58.3] 11.5 [0–56.7]
Steroid therapy 46 (100) 20 (100) 13 (100) 13 (100)
Calcineurin Inhibitor immunosuppression therapy 46 (100) 20 (100) 13 (100) 13 (100)
Statin therapy 46 (100) 20 (100) 13 (100) 13 (100)
HTN 20 (43.5) 7 (35) 9 (69.2) 4 (30.8)
Diabetes 1. T1 = 8 (17.8)
2. T2 = 9 (26)
1. T1 = 5 (25)
2. T2 = 1 (5)
1. T2 = 2 (15.4) 1. T1 = 3 (25)
2. T2 = 6 (50)
Hospitalisations 14 (30.4) 8 (40)
1. Planned = 1
2. Unplanned = 7
4 (15.4)
1. Planned = 1
2. Unplanned = 3
2 (15.4)
1. Planned = 1
2. Unplanned = 1
Rejection episodes 6 (13%) 3 (15%) 1 (7.7%) 2 (18.2%)
NODAT 6 (13%) 2 (10%) 4 (30.8) 4 (30.8)
CVE 2 (4.3%) 0 1 = DO 1 = DO
Deaths 0 0 0 0
Means and Standard deviations are presented for continuous data. Frequency numbers and proportional percentages are shown for categorical variables
and events. Length of time on dialysis prior transplant is expressed in Median with inter quartile ranges. KTx = kidney transplant, Tx = transplant,
HTN = hypertension, NODAT = New onset of Diabetes after transplant, CVE = cardiovascular event, W = white, B = black, A = Asian, 1st = 1st Tx,
2nd = 2nd Tx, 3rd = 3rd Tx, SPK = simultaneous pancreas kidney Tx, L = live donor and C = cadaveric donor.
doi:10.1371/journal.pone.0171063.t001
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This pilot study offered patients 12 weeks of supervised training, followed by 9 months of
self-managed physical activity. In contrast to previous studies in haemodialysis patients, where
PWV values revert back to baseline values after only one month cessation of the supervised
exercise intervention [17, 18], this current study demonstrates a significant mean difference
that exceeds the MCID even at 9-month follow-up. Interventions in this current study were
provided by specialist renal physiotherapists who were trained in motivational interviewing
[24]. Patient engagement, with transition from supervised training to self-managed physical
activity programmes, was facilitated by these trained individuals. The importance of specialist
Table 2. Long-term outcomes at 9-month follow-up-, and results of 9-month follow-up ANCOVA analysis.
Variable Baseline (n = 46) 12weeks (n = 46) 12months (n = 42) 9-month follow-up assessment
ANCOVA
UC
(n = 20)
AT
(n = 13)
RT
(n = 13)
UC
(n = 20)
AT
(n = 13)
RT
(n = 20)
UC
(n = 20)
AT
(n = 12)
RT
(n = 10)
Groups Between
-group X diff
95% CI p-
value
Arterial stiffness
PWV (m/sec) 8.9±2.3 9.0±1.4 9.1±1.8 9.4±2.3a 8.4±1.6a 7.7±1.4a 8.9±1.6 8.2±1.9 8.1±1.2 AT/UC -1.05 -2.11,
0.017
0.05*
RT/UC -1.30 -2.44,
-0.17
0.03*
Cardio pulmonary exercise test secondary variables
Relative
VO2peak (ml/
kg/min)
11.8
±3.0
12.3
±4.8
14.1
±4.0
12.8
±3.0
15.1
±5.3a
16.8
±3.9a
15.9
±5.2
16.2
±6.4
13.4
±3.9
AT/UC 2.20 0.37,
4.02
0.02*
RT/UC 0.89 -1.10,
2.89
0.39
Absolute
VO2peak (L/
min)
0.8±0.2 0.9±0.4 1.1±0.6 1.0±0.4 1.1±0.3a 1.2±0.6a 1.1±0.5 1.2±0.6 1.1±0.3 AT/UC 0.08 -0.09,
0.25
0.36
RT/UC 0.07 -0.12,
0.26
0.47
RER 1.0±0.0 1.1±0.1 1.0±0.1 1.0±0.0 1.1±0.2 1.0±0.1 1.1±0.1 1.0±0.3 1.0±0.1 AT/UC -0.07 -0.22,
0.09
0.41
RT/UC -0.002 -0.17,
0.17
0.97
Body mass
(kg)
71.6
±10.8
76.3
±15.6
79.4
±13.8
76.9
±12.1a
78.5
±16.9
79.5
±14.8
72.5
±15.9
77.8
±14.8
82.3
±12.8
AT/UC 0.29 -3.51,
4.10
0.87
RT/UC 3.29 -0.73,
7.16
0.09
Resting SBP
(mmHg)
133.9
±11.6
136.8
±14.4
135.9
±13.3
135.7
±12.4
134.9
±12.2
136.0
±13.3
132.2
±11.7
134.6
±15.5
136.9
±13.2
AT/UC -0.8 8.78,
7.16
0.83
RT/UC 2.08 -6.45,
10.59
0.62
Resting DBP
(mmHg)
71.4
±8.4
77.6
±13.7
81.7
±12.5
73.5
±8.7
75.1
±14.0
84.7
±10.7
76.9
±8.4
76.6
±10.9
74.2
±10.6
AT/UC -1.93 -8.39,
4.52
0.54
RT/UC -3.79 -10.66,
3.07
0.26
(n = 46 at baseline for PWV, weight, SBP, DBP and all V02peak related variables. N = 42 at 12months for PWV, weight, SBP and DBP. VO2peak related
data n = 37 at 12 months).
Values are expressed as means and standard deviations. VO2peak = peak oxygen uptake, CPET = cardiopulmonary exercise test, HR = heart rate,
SBP = systolic blood pressure, DBP = Diastolic BP. Significance p<0.05.
a Indicates within-group significance from baseline to 12 weeks. There were no significant within-group differences in variables from 12 weeks to9-month
follow-up assessment.
* significant mean between-group difference from ANCOVA analysis (allowing for mean baseline values, age and length of time on dialysis pre-
transplantation).
doi:10.1371/journal.pone.0171063.t002
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Fig 2. Individual PWV results (m/sec) in each group at baseline, 12 weeks and 12 months (9-month
follow-up). (A) UC group (n = 20), (B) AT group (n = 12), and (C) RT group (n = 10).
doi:10.1371/journal.pone.0171063.g002
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Fig 3. Individual relative VO2peak values (ml/min/kg) in each group at baseline, 12 weeks and 12
months (9-month follow-up). (A) UC group (n = 20), (B) AT group (n = 9), and (C) RT group (n = 8).
doi:10.1371/journal.pone.0171063.g003
Long-term exercise outcomes in kidney transplant recipients
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exercise personnel to sustain positive exercise behavior has been highlighted in the literature
[26–29]. A weight management programme delivered by specialist renal physiotherapists,
which utilises the same self-management exercise counseling techniques, demonstrated
improved exercise capacity and functional ability after 12 months of self-managed physical
activity [30].
The effects of resistance training on endothelial function and arterial stiffness remain
largely unexplored in the kidney transplant literature. The plausible mechanisms responsible
for improvements in PWV with this form of exercise intervention, as demonstrated by 12
week and 9-month follow-up results, remain unclear. It has been hypothesised that improve-
ments in PWV following 3 months of exercise intervention in haemodialysis patients [17–
19] may be due to reductions in systolic blood pressure following exercise interventions.
Whilst this study did not reveal significant differences in blood pressure between interven-
tions and usual care, this may be explained by the tightly controlled anti-hypertensive
regimes in post-transplant care. Although muscle strength was not assessed at 9-month fol-
low-up assessment, 12-week analysis [11] did reveal a significant improvement, and associa-
tion in muscle strength and PWV, when comparing RT to UC. It is recognized that the RT
group had a shorter median time exposure to haemodialysis therapy when compared with
UC or AT participants. Whilst this has been controlled for in statistical analyses, it is
acknowledged that increased exposure to haemodialysis-related uraemic symptoms has a
reported negative effect on vascular health [31], and this must be taken into consideration
when interpreting the results. Due to a number of dropouts by the 9-month follow-up point,
there was a resultant imbalance in gender distribution in the AT group (Table 1). Although
there has been several investigations into the effect of gender as a determinant of PWV, it is
suggested that this is not an independent determinant for this outcome [32]. Future studies
should assess the physiological mechanisms responsible for change in PWV in this patient
population, such as endothelial function.
At 9-month follow-up, there was a significant between-group difference in relative
VO2peak when comparing AT with UC, however, there were no significant between-group
differences found in absolute VO2peak values at this time point. It is likely that a lack of signifi-
cant difference in absolute VO2peak values when comparing either intervention group with
usual care may be due to the non-significant weight increase seen in both intervention groups
(Table 2). Additionally, there were more males than females in the AT group and as there is a
possible gender bias with regard to VO2peak outcomes [33], caution should be taken with
interpretation of these results.
The baseline VO2peak values in this current study are significantly lower than those previ-
ously reported in other randomized controlled trials in kidney transplant recipients [8–10].
The values also fall below the previously reported value of 17.85ml/kg/min [21], which is asso-
ciated with a survival advantage in kidney transplant recipients. The low baseline values are
possibly reflective of a pragmatic recruitment of any kidney transplant patient who attended a
UK National Health Service clinic, and who fulfilled the inclusion criteria for the study, rather
than targeting those individuals who were already physically active.
To our knowledge, this is the first long-term follow-up study to examine PWV and
VO2peak in KTx recipients following an un-supervised period of self-managed physical activ-
ity. A 12-month, unsupervised, exercise study by Painter et al [8] reported a 42% attrition rate
at 12 months. This current pilot study reports an attrition rate of 30% at the 12 month time
point (9-month follow-up assessment), which is comparable to the exercise literature in other
stages of the CKD trajectory [34]. It is acknowledged however that the dropouts from the cur-
rent study, which were limited to the intervention groups, may have resulted in a selection bias
that could have influenced the results.
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Further limitations include; small sample size, and no formal assessment of patient engage-
ment and adherence with the self-managed exercise recommendations. Assessment of muscle
mass, body composition and endothelial function could have also provided insight into mech-
anisms responsible for change in PWV and relative VO2peak outcomes, and should be encour-
aged in further research to elucidate potential mechanisms for change in exercise related
outcomes.
Conclusion
Possible long-term gains in PWV and VO2peak outcomes for new kidney transplant recipients
with only 12 weeks of supervised exercise training appears to be feasible. However, large-scale
investigations into which type of exercise intervention is most effective for improving out-
comes in the short, and longer term are required to confirm this. Please refer to S1 and S2 Figs
for study protocol and consort checklist. Refer to S1 Table for raw data.
Supporting information
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S1 Table. supplementary raw data.
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S2 Fig. Consort checklist.
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